157 related articles for article (PubMed ID: 3766229)
21. Pyrimidine metabolism in Tritrichomonas foetus.
Jarroll EL; Lindmark DG; Paolella P
J Parasitol; 1983 Oct; 69(5):846-9. PubMed ID: 6200591
[TBL] [Abstract][Full Text] [Related]
22. Combination of the chemotherapeutic agent 5-fluorouracil with an inhibitor of its catabolism results in increased micronucleus induction.
Stopper H; Kühnel A; Podschun B
Biochem Biophys Res Commun; 1994 Sep; 203(2):1124-30. PubMed ID: 8093030
[TBL] [Abstract][Full Text] [Related]
23. Pyrimidine catabolism: individual characterization of the three sequential enzymes with a new assay.
Traut TW; Loechel S
Biochemistry; 1984 May; 23(11):2533-9. PubMed ID: 6433973
[TBL] [Abstract][Full Text] [Related]
24. Distribution and inhibition of dihydrouracil dehydrogenase activities in human tissues using 5-fluorouracil as a substrate.
Ho DH; Townsend L; Luna MA; Bodey GP
Anticancer Res; 1986; 6(4):781-4. PubMed ID: 3752956
[TBL] [Abstract][Full Text] [Related]
25. Screening for defects of dihydropyrimidine degradation by analysis of amino acids in urine before and after acid hydrolysis.
van Gennip AH; Driedijk PC; Elzinga A; Abeling NG
J Inherit Metab Dis; 1992; 15(3):413-5. PubMed ID: 1405482
[No Abstract] [Full Text] [Related]
26. In vivo inhibition of pyrimidine catabolism by 5-cyanouracil.
Gentry GA; Morse PA; Dorsett MT
Cancer Res; 1971 Jun; 31(6):909-12. PubMed ID: 5088491
[No Abstract] [Full Text] [Related]
27. Pyrimidine metabolism in Giardia lamblia trophozoites.
Lindmark DG; Jarroll EL
Mol Biochem Parasitol; 1982 May; 5(5):291-6. PubMed ID: 7099205
[TBL] [Abstract][Full Text] [Related]
28. Utilization of exogenous pyrimidines as a source of nitrogen by cells of the yeast Rhodotorula glutinis.
Milstein OA; Bekker ML
J Bacteriol; 1976 Jul; 127(1):1-6. PubMed ID: 945262
[TBL] [Abstract][Full Text] [Related]
29. Potentiation of the teratogenic effects of 5-fluorouracil by natural pyrimidines. I. Biological aspects.
Wilson JG; Jordan RL; Schumacher H
Teratology; 1969 May; 2(2):91-7. PubMed ID: 5790157
[No Abstract] [Full Text] [Related]
30. Combined deficiencies of NADPH- and NADH-dependent dihydropyrimidine dehydrogenases, a new finding in a family with thymine-uraciluria.
van Gennip AH; van Lenthe H; Abeling NG; Bakker HD; van Kuilenburg AB
J Inherit Metab Dis; 1995; 18(2):185-8. PubMed ID: 7564242
[No Abstract] [Full Text] [Related]
31. Inhibitory action of thymine ribonucleoside and other pyrimidine derivatives on the cleavage of 5-iodo-deoxy-uridine by mouse-liver extract.
Fox BW; Perkins JP; Prusoff WH
Chem Biol Interact; 1970 Apr; 1(4):331-40. PubMed ID: 4258869
[No Abstract] [Full Text] [Related]
32. Effect of coadministration of thymine or thymidine on the antitumor activity of 1-(2-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil.
Fujii S; Kitano S; Ikenaka K; Fukushima M; Nakamura H; Maehara Y; Shirasaka T
Gan; 1980 Feb; 71(1):100-6. PubMed ID: 6769735
[TBL] [Abstract][Full Text] [Related]
33. Inhibition by 6-aminothymine of the degradation of nucleosides (5-iododeoxyuridine, thymidine) and pyrimidine bases (5-iodouracil, uracil and 5-fluorouracil) in vivo.
Matthes E; Bärwolff D; Langen P
Acta Biol Med Ger; 1974; 32(5):483-502. PubMed ID: 4852467
[No Abstract] [Full Text] [Related]
34. Liver dihydropyrimidine dehydrogenase activity in human, cynomolgus monkey, rhesus monkey, dog, rat and mouse.
Sludden J; Hardy SC; VandenBranden MR; Wrighton SA; McLeod HL
Pharmacology; 1998 May; 56(5):276-80. PubMed ID: 9597696
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of rat dihydropyrimidine dehydrogenase by 5-cyanouracil in vitro.
Dorsett MT; Morse PA; Gentry GA
Cancer Res; 1969 Jan; 29(1):79-82. PubMed ID: 5763982
[No Abstract] [Full Text] [Related]
36. Dihydropyrimidine dehydrogenase deficiency leading to thymine-uraciluria. An inborn error of pyrimidine metabolism.
Berger R; Stoker-de Vries SA; Wadman SK; Duran M; Beemer FA; de Bree PK; Weits-Binnerts JJ; Penders TJ; van der Woude JK
Clin Chim Acta; 1984 Aug; 141(2-3):227-34. PubMed ID: 6488556
[TBL] [Abstract][Full Text] [Related]
37. Circadian rhythm of rat liver dihydropyrimidine dehydrogenase. Possible relevance to fluoropyrimidine chemotherapy.
Harris BE; Song RL; He YJ; Soong SJ; Diasio RB
Biochem Pharmacol; 1988 Dec; 37(24):4759-62. PubMed ID: 3202908
[TBL] [Abstract][Full Text] [Related]
38. Comparative studies on the metabolism of new fluorinated pyrimidine drugs in the liver by in vivo 19F magnetic resonance spectroscopic observation.
Harada M; Nishitani H; Koga K; Miura I; Kimura A
Jpn J Cancer Res; 1993 Feb; 84(2):197-202. PubMed ID: 8463136
[TBL] [Abstract][Full Text] [Related]
39. Effect of 5-diazouracil on the synthetic and catabolic utilization of thymine in rat liver.
Ferdinandus JA; Weber G
Proc Soc Exp Biol Med; 1972 Feb; 139(2):592-6. PubMed ID: 5059050
[No Abstract] [Full Text] [Related]
40. Effect of vitamin B2 deficiency on rat liver dihydropyrimidine dehydrogenase activity.
Fujimoto S; Matsuda K; Kikugawa M; Kaneko M; Tamaki N
J Nutr Sci Vitaminol (Tokyo); 1991 Feb; 37(1):89-98. PubMed ID: 1880634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
